Beyond Air, Inc. Material Event - What Happened

If you follow Beyond Air, Inc. (ticker: XAIR), you may have seen recent news regarding their standing on the Nasdaq. I’ve broken down exactly what is happening so you can understand the situation without digging through complex legal filings.

1. What happened?

Beyond Air received a formal notice from the Nasdaq Stock Market. The company is currently not meeting the minimum price requirement. Nasdaq rules require stocks to trade at $1.00 or higher for 30 consecutive business days. Because XAIR shares have fallen below this threshold, the company was warned that it faces potential removal from the exchange.

2. Why did it happen?

This is a valuation issue. Beyond Air develops medical devices using nitric oxide, but its stock price has struggled. Investors are currently concerned about the company’s "burn rate"—it reported a loss of about $10.6 million for the quarter ending December 31, 2025. Additionally, market confidence has been impacted by slower-than-expected sales of the LungFit PH system.

3. Why does this matter?

This is a critical moment for the company. If Nasdaq removes the stock, it would be relegated to "Over-the-Counter" (OTC) markets. This makes the stock harder to trade, less visible to large institutional investors, and generally more volatile. Staying on the Nasdaq is vital for the company’s credibility and its ability to raise the capital needed to fund ongoing research and sales efforts.

4. Who is affected?

• Investors: Shareholders are currently facing higher volatility. The low stock price reflects a lack of market confidence in the company’s current path to profitability.
• The Company: Management is now under pressure to present a "Plan of Compliance" to the Nasdaq Hearings Panel. They may propose solutions such as a reverse stock split, new financing, or a shift in business strategy to improve performance.

5. What happens next?

The threat of removal is paused while the company prepares for its hearing on May 14, 2026. After the hearing, the panel will decide the company's fate. They may grant an extension of up to 180 days to allow the company to fix the price issue, or they may deny the request, which would lead to the stock's removal from the exchange.

6. What should investors consider?

• Stay alert: A Nasdaq deficiency notice is a serious red flag. The stock is now in "penny stock" territory, which carries higher risk and lower transparency.
• Watch the calendar: Keep May 14, 2026, on your radar. Expect increased price swings leading up to and immediately following the panel’s decision.
• Focus on the fundamentals: If you are considering an investment, look closely at the next earnings report. You’ll want to see evidence that the company is successfully growing sales or effectively cutting costs to extend its cash runway.
• Understand the risk: If the company fails to convince the panel, a move to a less liquid exchange could put further downward pressure on the share price.

Disclaimer: I am an AI, not a financial advisor. This summary is for informational purposes only and is not professional investment advice. Always do your own research before making any investment decisions.